Category: Biolase Technology Inc.Syndicate content

Biolase cuts costs ahead of a potential sale, posts losses in Q4

March 11, 2014 by Arezu Sarvestani

Medical lasers maker Biolase is still examining "strategic alternatives" for the company as its slashes about $1.3 million from its payroll and posts continued quarterly losses.

Biolase cuts costs ahead of a potential sale, posts losses in Q4

California medtech company Biolase (NSDQ:BIOL) is looking to slim down ahead of a potential acquisition as the company examines its "strategic alternatives."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase closes $5M private placement with Oracle

February 20, 2014 by Chris Walker

Biolase ties the bow on a $5 million private placement with Oracle Investment Management it plans to use to pay down debt.

Biolase lands $5M investment

Biolase (NSDQ:BIOL) said it closed a $5 million private placement with Oracle Investment Management.

The surgical laser maker sold off a little more than 1.9 million shares for $2.57 each, with the deal closing on Feb. 10. The money is expected to go toward paying down its $4.6 million credit facility with Comerica Bank, according to chairman & CEO Federico Pignatelli .

Biolase adds 2 to board, taps Piper Jaffray for advice on 'strategic alternatives'

December 13, 2013 by Arezu Sarvestani

Medical lasers maker Biolase adds 2 new directors to its board and engages Piper Jaffray & Co. as its exclusive financial advisor as it continues to evaluate a potential sale.

Biolase adds 2 to board, taps Piper Jaffray for financial advice

Biolase tanks on gaping Q3 losses, fires sales & marketing veeps, will seek acquirer

November 12, 2013 by Brad Perriello

Biolase shares tank after the medical device company reports gaping 3rd-quarter losses and sacks its sales vice presidents, saying it will court a potential acquirer.

Biolase tanks on gaping Q3 losses, fires sales & marketing veeps, will seek acquirer

Biolase, Auris in co-development deal for eye surgery robot

October 18, 2013 by Chris Walker

Biolase and Auris Surgical Robotics ink a deal to co-develop a cataract-removal ophthalmological robot.

Biolase, Auris in co-development deal for eye robot

Biolase (NSDQ:BIOL) and Auris Surgical Robotics said they've inked a deal to collaborate on developing a cataract-removal ophthalmologic robot.

Class action lawsuit accuses Biolase and officers of lying to investors

August 29, 2013 by Sony Salzman

A group of Biolase shareholders are suing in a class action lawsuit accusing company directors of lying about its financial struggles.

Class action lawsuit goes after Biolase directors

Biolase (NSDQ:BLTI) is facing a lawsuit brought by shareholders accusing the company of hiding problems by lying on quarterly earnings reports. The lawsuit claims Biolase and its directors concealed liquidity and solvency issues as well as under-performing sales.

New Rotation Medical CEO hails from Zimmer, Covidien | Personnel Moves

July 29, 2013 by Sony Salzman

Martha Shadan, a former executive for the likes of Zimmer and Covidien, will take the reins at young orthotics company Rotation Medical.

fired/hired

Minnesota-based orthotics company Rotation Medical appointed Martha Shadan as the new president & CEO.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp